Erratum

Abstract

benefit is consistent for women of all ages, histology, grade, or pelvic nodal involvement; although this benefit may be less for women with the higher stages of disease. Finally, these results suggest additional benefit from giving further chemotherapy after chemoradiotherapy, which requires further testing in the context of randomised trials.